Filing Details

Accession Number:
0001209191-21-057633
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-24 16:51:26
Reporting Period:
2021-09-22
Accepted Time:
2021-09-24 16:51:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662579 C4 Therapeutics Inc. CCCC Biological Products, (No Disgnostic Substances) (2836) 475617627
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1824823 Elena Prokupets C/O C4 Therapeutics, Inc.
490 Arsenal Way #200
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-22 3,544 $50.10 39,492 No 4 S Indirect By Spouse
Common Stock Disposition 2021-09-22 7,004 $50.09 519,360 No 4 S Indirect By ERP Business Holdings, LP
Common Stock Disposition 2021-09-23 5,926 $50.35 33,566 No 4 S Indirect By Spouse
Common Stock Disposition 2021-09-23 446 $51.09 33,120 No 4 S Indirect By Spouse
Common Stock Disposition 2021-09-23 11,801 $50.35 507,559 No 4 S Indirect By ERP Business Holdings, LP
Common Stock Disposition 2021-09-23 1,007 $51.08 506,552 No 4 S Indirect By ERP Business Holdings, LP
Common Stock Disposition 2021-09-24 900 $50.11 32,220 No 4 S Indirect By Spouse
Common Stock Disposition 2021-09-24 2,115 $50.10 504,437 No 4 S Indirect By ERP Business Holdings, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Spouse
No 4 S Indirect By ERP Business Holdings, LP
No 4 S Indirect By Spouse
No 4 S Indirect By Spouse
No 4 S Indirect By ERP Business Holdings, LP
No 4 S Indirect By ERP Business Holdings, LP
No 4 S Indirect By Spouse
No 4 S Indirect By ERP Business Holdings, LP
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.04 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.